VBI
Vaccines Inc.


Board
of Directors Services Agreement 


 


This
Board of Directors Services Agreement (this “Agreement”), dated July 28, 2016 (the “Effective Date”),
is entered into between VBI Vaccines Inc., a corporation organized under the laws of British Columbia, Canada (the “Company”),
and Adam Logal, an individual (“Director”).


 


RECITALS


 


WHEREAS,
the Company desires to retain the services of Director for the benefit of the Company and its stockholders as of the Effective
Date; and


 


WHEREAS,
Director desires to serve on the Company’s Board of Directors as of the Effective Date for the period of time and subject
to the terms and conditions set forth herein.


 


NOW,
THEREFORE, for consideration as set forth herein, the parties hereto agree as follows:


 


AGREEMENT


 


1. Board
Duties.


 


(a)
Director agrees to provide services to the Company as a member of the Board of Directors as of the Effective Date. Director shall,
for so long as he remains a member of the Board of Directors, meet with the other members of the Board of Directors and/or the
Company’s executive officers upon request, at dates and times mutually agreeable to the parties, to discuss any matter involving
the Company (including any subsidiary). Director acknowledges and agrees that the Company may rely upon Director’s expertise
in business disciplines where Director has significant experience with respect to the Company’s business operations and
that such requests may require substantial additional time and efforts in addition to Director’s customary service as a
member of the Board of Directors.


 


(b)
Director understands that as a member of the Board of Directors he is bound by a fiduciary duty and a duty of care to the Company.
As such, Director must act honestly and in good faith with a view to the best interests of the Company and exercise the care,
diligence and skill that a reasonably prudent individual would exercise in comparable circumstances. Membership on the Board of
Directors shall require adherence to board member conduct policies adopted by the Board of Directors and enforced equally upon
all directors.


 


2.
Compensation. 


 


(a) Board
Compensation. As compensation for the services provided herein, effective May 6, 2016, the Company shall pay to
Director (or his designee), so long as Director continues to fulfill Director’s duties and to provide services pursuant
to this Agreement, quarterly compensation at the initial rate of $7,500.


 


(b) Committee
Stipend. As compensation for the services provided herein, as a member of the following committees of the Board of
Directors, effective May 6, 2016, the Company shall compensate Director (or his designee) as follows: Audit Committee –
As a chair of the committee, Director to receive quarterly compensation at the initial rate of $3,750;


 




    	 	 	 



     


    

 


provided,
however, that no such compensation for services as a director or committee member shall be paid to Director (or his designee)
if he is employed by the Company in any capacity. Such rates of compensation shall be subject to upward or downward adjustment,
in the sole discretion of the Board of Directors or any committee of the Board of Directors empowered to establish the compensation
of directors or committee members, upon written notice to Director, and any such adjustment shall not require an amendment to
this Agreement, which will remain in effect in accordance with its terms notwithstanding any such adjustment.


 


3. Reimbursement
of Expenses. The Company will reimburse Director for reasonable business expenses incurred on behalf of the Company in
discharging Director’s duties as a member of the Board of Directors, provided that such expenses are approved in
advance by the Company’s Chief Executive Officer or Chief Financial Officer and provided further that Director shall
provide the Chief Financial Officer with reasonable substantiating documentation relating to such expenses prior to
reimbursement. Upon the conclusion of Director’s service hereunder, any property of the Company, including, without
limitation, laptops, personal computers and related equipment, used by Director may (if the Company agrees) be purchased by
Director from the Company at its then current fair market value, to be determined in good faith by the Chief Financial
Officer of the Company, or returned to the Company.


 


4.
Non-Disparagement. Director agrees to forbear from making, causing to be made, publishing, ratifying or endorsing any and
all disparaging remarks, derogatory statements or comments to any third party with respect to the Company and its affiliates,
including, without limitation, the Company’s parent, subsidiaries, officers, directors and employees (collectively,
“Company Parties”). Further, Director hereby agrees to forbear from making any public or non-confidential
statement with respect to any of the Company Parties. The duties and obligations of this paragraph 4 shall continue following
the termination of this Agreement.


 


5.
Confidentiality. Director agrees that Director will have access to and become acquainted with confidential proprietary
information of the Company and its subsidiaries (“Confidential Information”) which is owned by the Company and
its subsidiaries and is regularly used in the operation of the Company’s and its subsidiaries businesses. As used in
this Agreement, the term “Confidential Information” shall mean proprietary and non-public information that is not
disclosed by the Company in its filings with the Securities and Exchange Commission (the “SEC”). Director agrees
that the term “Confidential Information” as used in this Agreement is to be broadly interpreted and includes (i)
information that has, or could have, commercial value for the business in which the Company or any of its subsidiaries is
engaged, or in which the Company or its subsidiaries may engage at a later time, and (ii) information that, if disclosed
without authorization, could be detrimental to the economic interests of the Company or any of its subsidiaries. Director
agrees that the term “Confidential Information” includes, without limitation, any patent, patent application,
copyright, trademark, trade name, service mark, service name, “know-how,” negative “know-how,” trade
secrets, customer and supplier identities, characteristics and terms of agreement, details of customer or consultant
contracts, pricing policies, operational methods, marketing plans or strategies, product development techniques or plans,
business acquisitions plans, science or technical information, ideas, discoveries, designs, computer programs (including
source codes), financial forecasts, unpublished financial information, budgets, processes, procedures, formulae,
improvements or other proprietary or intellectual property of the Company, whether or not in written or tangible form, and
whether or not registered, and including all memoranda, notes, summaries, plans, reports, records, documents and other
evidence thereof. Director acknowledges that all Confidential Information, whether prepared by Director or otherwise acquired
by Director in any other way, shall remain the exclusive property of the Company. Director promises and agrees that Director
shall not misuse, misappropriate, or disclose in any way to any person or entity any of the Company’s Confidential
Information, either directly or indirectly, nor will Director use the Confidential Information in any way or at any time
except as required in the course of Director’s business relationship with the Company. Director agrees that the sale or
unauthorized use or disclosure of any of the Company’s Confidential Information constitutes unfair competition.
Director promises and agrees not to engage in any unfair competition with the Company and will take measures that are
appropriate to prevent its employees or contractors from engaging in unfair competition with the Company. Director further
agrees that, at any time, upon the request of the Company and without further compensation, but at no expense to Director,
Director shall perform any lawful acts, including the execution of papers and oaths and the giving of testimony, that in the
opinion of the Company, its successors or assigns, may be necessary or desirable in order to obtain, sustain, reissue and
renew, and in order to enforce, perfect, record and maintain, patent applications and United States and foreign patents
on the Company’s or its subsidiaries’ inventions, and copyright registrations on the Company’s or its
subsidiaries’ inventions. The duties and obligations of this paragraph 5 shall continue following the termination of
this Agreement.


 




    	 	 	 



     


    

 


6. Term. Except
as otherwise provided herein, the term of this Agreement and the duties and obligations of Director and the Company under it
shall continue until the later of (i) the date that the Company’s stockholders fail to re-elect Director as a member of
the Company’s Board of Directors, including as a result of the failure by the Company to nominate Director as a
candidate for election, or (ii) the date that Director ceases to be a member of the Company’s Board of Directors for
any reason. Director may voluntarily resign Director’s position on the Board of Directors at any time and such
resignation shall not be considered a breach of this Agreement.


 


7. Cooperation. Director
will notify the Company promptly if Director is subpoenaed or otherwise served with legal process in any matter involving the
Company or any subsidiary and will cooperate in the review, defense or prosecution of any such matter. Director will
notify the Company if any attorney who is not representing the Company contacts or attempts to contact Director (other than
Director’s own legal counsel) to obtain information that in any way relates to the Company or any subsidiary, and
Director will not discuss any of these matters with any such attorney without first so notifying the Company and providing
the Company with an opportunity to have its attorney present during any meeting or conversation with any such attorney. In
the event of any claim or litigation against the Company or Director based upon any alleged conduct, acts or omissions of
Director during Director’s tenure as a director of the Company, Director will provide to the Company such information
and documents as are necessary and reasonably requested by the Company or its counsel, subject to restrictions imposed by
federal or state securities laws or court order or injunction. The foregoing shall be subject to the terms and conditions of
any indemnification agreement entered into between the Company and Director, the terms and conditions of which shall govern
and shall supersede this paragraph 7 in the event of any conflict between this paragraph 7 and such indemnification
agreement.


 


8.
Entire Agreement. This Agreement represents the entire agreement among the parties with respect to the subject matter
herein.


 


9. Governing
Law. This Agreement shall be governed by the law of the State of Delaware. Any action or proceeding arising out of or
relating to this Agreement shall be filed in and heard and litigated solely before the federal courts of New York located
within the Borough of Manhattan. Each party generally and unconditionally accepts the exclusive jurisdiction of such courts
and venue therein.


 


10. Injunctive
Relief. It is agreed that the rights and benefits of the Company pursuant to Sections 1, 4, 5 and 7 of this Agreement
are unique and that no adequate remedy exists at law if Director shall fail to perform, or breaches, any of Director’s
obligations thereunder, that it would be difficult to determine the amount of damages resulting therefrom, and that any such
breach would cause irreparable injury to the Company. Therefore, the Company shall be entitled to injunctive relief to
prevent or restrain any such breach of this Agreement by Director.


 




    	 	 	 



     


    

 


11.
Insurance. The Company shall use commercially reasonable efforts to maintain directors’ and officers’
liability insurance throughout the term of Director’s service to the Company as a director, in amounts and with such
carrier(s) and on such terms as determined by the Board of Directors, or any committee of the Board of Directors empowered
for such purpose.


 


12. Requirements
of Director. During the term of Director’s services to the Company hereunder, Director shall observe all
applicable laws, rules and regulations relating to independent directors of a public company as promulgated from time to
time, including acting in accordance with the Business Corporations Act (British Columbia) (the “BCBCA”) as set
out in Section 1(b) of this Agreement, the regulations thereto, and the notice of articles and articles of the
Company.


 


13. Reporting
Obligations. While this Agreement is in effect, Director shall immediately report to the Company in the event: (i)
Director knows or has reason to know or should have known that any of the requirements specified in Section 12 hereof is not
satisfied or is not going to be satisfied; (ii) Director is nominated to the board of directors or becomes an officer of
another public company or (iii) Director knows or has reason to know of any actual or potential conflict of
interest.


 


[Signature
page follows.]


 




    	 	 	 



     


    

 


In
witness whereof, the parties hereto enter
into this Agreement as of the date first set forth above.


 


	 	THE
    COMPANY:
	 	 	 
	 	VBI
    Vaccines Inc.
	 	 	 
	 	By:	/s/
    Jeff Baxter
	 	Name:	Jeff
    Baxter
	 	Title:	Chief
    Executive Officer
	 	 	 
	 	DIRECTOR:
	 	 	 
	 	/s/
    Adam Logal
	 	Adam
    Logal